Literature DB >> 5352659

Cytosine arabinoside therapy for disseminated herpes zoster in a patient with IgG pyroglobulinemia.

E M McKelvey, H C Kwaan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5352659

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Varicella-zoster virus and subcutaneous cytarabine: correlation of in vitro sensitivities to blood levels.

Authors:  D A Zaky; R F Betts; R G Douglas; K Bengali; G L Neil
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

2.  Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains.

Authors:  M Fiala; A Chow; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

3.  Cytosine arabinoside therapy for herpes simplex encephalitis--clinical experience with six patients.

Authors:  A W Chow; A Roland; M Fiala; W Hryniuk; M L Weil; J S Geme; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1973-03       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.